Skip to content

Castle Biosciences CSTL Intangible assets — net

Intangible assets — net at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
Veracyte logo
VeracyteVCYT
NeoGenomics logo
NeoGenomicsNEO
GeneDx Holdings logo
GeneDx HoldingsWGS
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
Tempus AI, Inc. logo
Tempus AI, Inc.TEM

Other financials

Income statement

See full
Revenue$83.7M-4.9%
Gross profit$63.1M-11.8%
Operating income-$18.4M+34.1%
Net income-$14.5M+43.8%
EPS (diluted)-$0.49+45.6%

Balance sheet

See full
Cash & equivalents$63.8M-28.9%
Total debt$36.7M+42.1%
Total equity$461.4M+4.8%
Total assets$547.8M+9.2%

Cash flow

See full
Operating cash flow-$22.1M-267%
CapEx$12.5M+163%
Free cash flow-$34.6M-221%

Valuation

See full
Market cap$694.86M+29.9%
Enterprise value$667.82M+41.8%
P/S+0.5×

Profitability

See full
Gross margin77.9%-4.1pp
Operating margin-9.8%-30.8pp
Net margin-3.8%-10.2pp
FCF margin1.3%-10.7pp

Returns & leverage

See full
Return on equity-2.8%-10.6pp
Debt / equity0.1×0.0×
Current ratio6.7×-2.6×

Where this comes from

Reported directly by Castle Biosciences in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Castle Biosciences's intangible assets — net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Castle Biosciences's intangible assets — net?
Castle Biosciences (CSTL) reported intangible assets — net of $86.66M in Q1 2026.
How has Castle Biosciences's intangible assets — net changed year-over-year?
Castle Biosciences's intangible assets — net increased by 28.9% year-over-year, from $67.21M to $86.66M.